Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axonics Inc
(NQ:
AXNX
)
68.83
-0.01 (-0.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axonics Inc
< Previous
1
2
3
4
5
6
7
Next >
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
April 14, 2023
Via
Benzinga
Axonics to Report First Quarter 2023 Financial Results on May 1
April 10, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas
March 29, 2023
From
Axonics, Inc.
Via
Business Wire
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Axonics Modulation Tech Earnings Preview
February 28, 2023
Via
Benzinga
Analyst Ratings for Axonics
January 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023
March 24, 2023
Via
Benzinga
Axonics to Participate in the SUFU 2023 Winter Meeting
March 07, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results
March 01, 2023
From
Axonics, Inc.
Via
Business Wire
2 Fast-Growing Healthcare Stocks to Buy and Hold
December 02, 2022
The innovative companies have made great gains in a short period of time.
Via
The Motley Fool
Axonics Posts Smaller Than Expected Quarterly Loss, Raises Guidance
November 01, 2022
Via
Benzinga
Analyst Ratings for Axonics
October 21, 2022
Axonics (NASDAQ:AXNX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Axonics to Report Fourth Quarter 2022 Financial Results on March 1
February 08, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
January 31, 2023
From
Axonics, Inc.
Via
Business Wire
Why Axonics Shares Are Trading Higher Today?
January 11, 2023
Axonics, Inc. (NASDAQ: AXNX) shares are trading higher after the company reported preliminary fourth-quarter and full-year 2022 total net revenue results above estimates. The company also issued FY23...
Via
Benzinga
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
January 11, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Risk/Reward Ratio Is Less Favorable, Analyst Says While Downgrading Stock
October 10, 2022
Needham downgraded Axonics Inc (NASDAQ: AXNX) from Buy to Hold.
Via
Benzinga
Where Axonics Stands With Analysts
October 05, 2022
Within the last quarter, Axonics (NASDAQ:AXNX) has observed the following analyst ratings:
Via
Benzinga
Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
December 13, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in the Piper Sandler Healthcare Conference
November 18, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500™ List of the Fastest Growing Companies in North America
November 16, 2022
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports Third Quarter 2022 Financial Results
October 31, 2022
From
Axonics, Inc.
Via
Business Wire
Earnings Scheduled For October 31, 2022
October 31, 2022
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
October 21, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Upgrades
Via
Benzinga
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
October 05, 2022
Biotech isn't the only place to make money in health care this year.
Via
Investor's Business Daily
Piper Sandler Maintains Overweight Rating for Axonics: Here's What You Need To Know
October 05, 2022
Piper Sandler has decided to maintain its Overweight rating of Axonics (NASDAQ:AXNX) and raise its price target from $82.00 to $84.00. Shares of Axonics are trading down 1.5% over the last 24 hours, at...
Via
Benzinga
Is This Medical Gear Maker Ready To Continue Its Rally?
September 15, 2022
Medical gear maker Axonics rallied to a new high after an announcement that it entered the Canadian market. Is it set for bigger gains on strong revenue growth?
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.